2015 - Fellow of the Australian Academy of Health and Medical Science
Nicholas M. Fisk mostly deals with Fetus, Pregnancy, Obstetrics, Surgery and Gestation. His work carried out in the field of Fetus brings together such families of science as Anesthesia, Gestational age, Andrology, Internal medicine and Mesenchymal stem cell. He usually deals with Internal medicine and limits it to topics linked to In utero and Endocrinology.
In his research, Microchimerism and Physiology is intimately related to Immunology, which falls under the overarching field of Pregnancy. His work deals with themes such as Amniocentesis, Cohort study, Amniotic fluid, Gynecology and Uterine artery, which intersect with Obstetrics. His biological study spans a wide range of topics, including Twin Twin Transfusion Syndrome, Umbilical cord, Ultrasound, Twin Pregnancy and Umbilical artery.
His scientific interests lie mostly in Fetus, Obstetrics, Pregnancy, Internal medicine and Mesenchymal stem cell. His study looks at the intersection of Fetus and topics like Surgery with Twin Twin Transfusion Syndrome. His Obstetrics study deals with Amniotic fluid intersecting with Oligohydramnios.
His specific area of interest is Pregnancy, where Nicholas M. Fisk studies In utero. His Internal medicine study integrates concerns from other disciplines, such as Endocrinology and Cardiology. The Mesenchymal stem cell study combines topics in areas such as Andrology, Stromal cell, Stem cell and Immunology.
Nicholas M. Fisk mainly focuses on Mesenchymal stem cell, Stem cell, Immunology, Progenitor cell and Fetus. His Mesenchymal stem cell research integrates issues from Andrology, Stromal cell, Bone marrow and Transplantation. His studies in Stem cell integrate themes in fields like Embryonic stem cell, Homeobox protein NANOG, Induced pluripotent stem cell, Cellular differentiation and Bioinformatics.
His Immunology study combines topics in areas such as Regenerative medicine, Microchimerism, Stem-cell therapy, Fetal Stem Cells and Regulation of gene expression. His Progenitor cell research includes elements of Skin wound, Angiogenesis, Cell therapy and Pathology. Fetus is the subject of his research, which falls under Pregnancy.
Nicholas M. Fisk spends much of his time researching Stem cell, Mesenchymal stem cell, Cellular differentiation, Pathology and Cell biology. He interconnects Embryonic stem cell, Andrology, Immunology and Amniotic epithelial cells in the investigation of issues within Stem cell. His Mesenchymal stem cell research incorporates elements of Stromal cell, Microchimerism, Biomedical engineering, Cell therapy and Transplantation.
His research integrates issues of Fetus, Fetal Stem Cells and Bone healing in his study of Pathology. In his research, Nicholas M. Fisk performs multidisciplinary study on Fetus and Tropism. The various areas that he examines in his Cell biology study include Adipocyte and Internal medicine.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow
Cesare Campagnoli;Irene A. G. Roberts;Sailesh Kumar;Phillip R. Bennett.
Association between maternal anxiety in pregnancy and increased uterine artery resistance index: cohort based study
Jeronima M. A. Teixeira;Nicholas M. Fisk;Vivette Glover.
Fetal exposure to maternal cortisol
Rachel Gitau;Alan Cameron;Nicholas M Fisk;Vivette Glover.
The Lancet (1998)
Human first-trimester fetal MSC express pluripotency markers and grow faster and have longer telomeres than adult MSC.
Pascale V. Guillot;Cecilia Gotherstrom;Jerry Chan;Hiroshi Kurata.
Stem Cells (2007)
Placental angioarchitecture in monochorionic twin pregnancies: Relationship to fetal growth, fetofetal transfusion syndrome, and pregnancy outcome ☆ ☆☆
Mark L. Denbow;Philip Cox;Myles Taylor;Donna M. Hammal.
American Journal of Obstetrics and Gynecology (2000)
Fetal plasma cortisol and β-endorphin response to intrauterine needling
X Giannakoulopoulos;V Glover;W Sepulveda;P Kourtis.
The Lancet (1994)
Fetal outcome in obstetric cholestasis
N. M. Fisk;G. N. B. Storey.
British Journal of Obstetrics and Gynaecology (1988)
Fetal hypothalamic-pituitary-adrenal stress responses to invasive procedures are independent of maternal responses
Rachel Gitau;Nicholas M. Fisk;Jeronima M. A. Teixeira;Alan Cameron.
The Journal of Clinical Endocrinology and Metabolism (2001)
Prenatal determination of fetal RhD type by DNA amplification.
P.R. Bennett;C. Le Van Kim;Y. Colin;R.M. Warwick.
The New England Journal of Medicine (1993)
Superior osteogenic capacity for bone tissue engineering of fetal compared with perinatal and adult mesenchymal stem cells.
Zhi‐Yong Zhang;Swee‐Hin Teoh;Mark S.K. Chong;Jan Thorsten Schantz.
Stem Cells (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: